US Stock MarketDetailed Quotes
GBIM GlobeImmune Inc(Switched to Pink Market)
- 0.000001
- 0.0000000.00%
15min DelayClose Jan 10 16:00 ET
5.75Market Cap0.00P/E (TTM)
0.000001High0.000001Low3.00KVolume0.000001Open0.000001Pre Close0.00Turnover0.08%Turnover Ratio0.00P/E (Static)5.75MShares0.00020052wk High0.00P/B3.70Float Cap0.00000152wk Low--Dividend TTM3.70MShs Float15.000000Historical High--Div YieldTTM0.00%Amplitude0.000001Historical Low0.000000Avg Price1Lot Size
About GlobeImmune Inc(Switched to Pink Market) Company
GlobeImmune, Inc. is a biopharmaceutical company. It engages in the development of therapeutic products for cancer and infectious diseases based on its proprietary Tarmogen platform. The company was founded by Donald Bellgrau, Richard C. Duke, and Alex Franzusoff on February 10, 1995 and is headquartered in Louisville, CO.
Company Profile
SymbolGBIM
Company NameGlobeImmune Inc(Switched to Pink Market)
Issue Price10.00
Founded1995
CEODr. Timothy C. Rodell, PhD.
MarketPink Market
Employees2
Fiscal Year Ends12-31
Address1450 Infinite Drive
CityLouisville
ProvinceColorado
CountryUnited States of America
Zip Code80027
Phone1-720-667-2300
Websitehttp://www.globeimmune.com
Company Executives
- Name
- Position
- Salary
- Dr. Timothy C. Rodell, PhD.
- Managing Director, President and Chief Executive Officer
- --
- C. Jeffrey Dekker
- Vice President, Finance, Treasurer and Secretary
- --
- Dr. J. William Freytag,PhD
- Chairman of the Board
- --
- Daniel J. Mitchell
- Independent Director
- --
- Augustine J. Lawlor
- Independent Director
- --
- S. Edward Torres
- Independent Director
- --
Heat List
US
Overall
Symbol
Price
% Chg
No Data